These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32191560)

  • 21. Progress in Gene Editing Tools and Their Potential for Correcting Mutations Underlying Hearing and Vision Loss.
    Botto C; Dalkara D; El-Amraoui A
    Front Genome Ed; 2021; 3():737632. PubMed ID: 34778871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there an unmet medical need for improved hearing restoration?
    Wolf BJ; Kusch K; Hunniford V; Vona B; Kühler R; Keppeler D; Strenzke N; Moser T
    EMBO Mol Med; 2022 Aug; 14(8):e15798. PubMed ID: 35833443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mini-Review: Cell Type-Specific Optogenetic Vision Restoration Approaches.
    Chaffiol A; Duebel J
    Adv Exp Med Biol; 2018; 1074():69-73. PubMed ID: 29721929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges.
    Delmaghani S; El-Amraoui A
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High spatial resolution artificial vision inferred from the spiking output of retinal ganglion cells stimulated by optogenetic and electrical means.
    Cojocaru AE; Corna A; Reh M; Zeck G
    Front Cell Neurosci; 2022; 16():1033738. PubMed ID: 36568888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding and treating paediatric hearing impairment.
    Wrobel C; Zafeiriou MP; Moser T
    EBioMedicine; 2021 Jan; 63():103171. PubMed ID: 33422987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Optogenetics and prosthetic treatment of retinal degeneration].
    Kirpichnikov MP; Ostrovskiy MA
    Vestn Oftalmol; 2015; 131(3):99-111. PubMed ID: 26310015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision.
    Chemi G; Brindisi M; Brogi S; Relitti N; Butini S; Gemma S; Campiani G
    Future Med Chem; 2019 Mar; 11(5):463-487. PubMed ID: 30907134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optogenetic stimulation of the auditory pathway for research and future prosthetics.
    Moser T
    Curr Opin Neurobiol; 2015 Oct; 34():29-36. PubMed ID: 25637880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empowering Retinal Gene Therapy with a Specific Promoter for Human Rod and Cone ON-Bipolar Cells.
    Hulliger EC; Hostettler SM; Kleinlogel S
    Mol Ther Methods Clin Dev; 2020 Jun; 17():505-519. PubMed ID: 32258214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innovative Optogenetic Strategies for Vision Restoration.
    Baker CK; Flannery JG
    Front Cell Neurosci; 2018; 12():316. PubMed ID: 30297985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optogenetics, visual prosthesis and electrostimulation for retinal dystrophies.
    Garg SJ; Federman J
    Curr Opin Ophthalmol; 2013 Sep; 24(5):407-14. PubMed ID: 23799487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging therapies for inherited retinal degeneration.
    Scholl HP; Strauss RW; Singh MS; Dalkara D; Roska B; Picaud S; Sahel JA
    Sci Transl Med; 2016 Dec; 8(368):368rv6. PubMed ID: 27928030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and subcellular optogenetic approaches towards neuroprotection and vision restoration.
    Wood EH; Kreymerman A; Kowal T; Buickians D; Sun Y; Muscat S; Mercola M; Moshfeghi DM; Goldberg JL
    Prog Retin Eye Res; 2023 Sep; 96():101153. PubMed ID: 36503723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considering optogenetic stimulation for cochlear implants.
    Jeschke M; Moser T
    Hear Res; 2015 Apr; 322():224-34. PubMed ID: 25601298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vision restoration: science fiction or reality?].
    Picaud S; Sahel JA
    Med Sci (Paris); 2020 Nov; 36(11):1038-1044. PubMed ID: 33151850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The functional characteristics of optogenetic gene therapy for vision restoration.
    Lindner M; Gilhooley MJ; Peirson SN; Hughes S; Hankins MW
    Cell Mol Life Sci; 2021 Feb; 78(4):1597-1613. PubMed ID: 32728765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved CoChR Variants Restore Visual Acuity and Contrast Sensitivity in a Mouse Model of Blindness under Ambient Light Conditions.
    Ganjawala TH; Lu Q; Fenner MD; Abrams GW; Pan ZH
    Mol Ther; 2019 Jun; 27(6):1195-1205. PubMed ID: 31010741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying and Managing Hearing and Vision Loss in Older People in Care Homes: A Scoping Review of the Evidence.
    Andrusjak W; Barbosa A; Mountain G
    Gerontologist; 2020 Apr; 60(3):e155-e168. PubMed ID: 31322168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards optogenetic vision restoration with high resolution.
    Ferrari U; Deny S; Sengupta A; Caplette R; Trapani F; Sahel JA; Dalkara D; Picaud S; Duebel J; Marre O
    PLoS Comput Biol; 2020 Jul; 16(7):e1007857. PubMed ID: 32667921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.